Attenuation of anti-ischemic efficacy during chronic therapy with nicorandil in patients with stable angina pectoris.

[1]  C. Pepine,et al.  Effects of intermittent transdermal nitroglycerin on occurrence of ischemia after patch removal: results of the second transdermal intermittent dosing evaluation study (TIDES-II). , 1997, Journal of the American College of Cardiology.

[2]  J. Parker,et al.  Intermittent transdermal nitroglycerin therapy in angina pectoris. Clinically effective without tolerance or rebound. Minitran Efficacy Study Group. , 1995, Circulation.

[3]  D. Kelly,et al.  Intermittent transdermal nitrates do not improve ischemia in patients taking beta-blockers or calcium antagonists: potential role of rebound ischemia during the nitrate-free period. , 1995, Journal of the American College of Cardiology.

[4]  H. Suryapranata.  Coronary haemodynamics and vasodilatory profile of a potassium channel opener in patients with coronary artery disease. , 1993, European heart journal.

[5]  D. Kelly,et al.  Efficacy, safety and duration of nitrate-free interval to prevent tolerance to transdermal nitroglycerin in effort angina. , 1992, European heart journal.

[6]  G. Pöch,et al.  Pharmacological interaction experiments differentiate between glibenclamide-sensitive K+ channels and cyclic GMP as components of vasodilation by nicorandil. , 1992, European journal of pharmacology.

[7]  G. Pöch,et al.  Molecular Mechanism of Action of Nicorandil , 1992, Journal of cardiovascular pharmacology.

[8]  G. Wagner.  Selected Issues From an Overview on Nicorandil: Tolerance, Duration of Action, and Long‐Term Efficacy , 1992, Journal of cardiovascular pharmacology.

[9]  E. Roland,et al.  Clinical profile of nicorandil: an overview of its hemodynamic properties and therapeutic efficacy. , 1992, Journal of cardiovascular pharmacology.

[10]  J. Abrams.  Clinical aspects of nitrate tolerance. , 1991, European heart journal.

[11]  J. Abrams.  Interval therapy to avoid nitrate tolerance: paradise regained? , 1989, The American journal of cardiology.

[12]  A. Camm,et al.  A controlled single-dose study of the efficacy, dose response and duration of action of nicorandil in angina pectoris. , 1989, The American journal of cardiology.

[13]  A. Camm,et al.  Exercise capacity after single and twice-daily doses of nicorandil in chronic stable angina pectoris. , 1989, The American journal of cardiology.

[14]  A. Kuroiwa,et al.  Effect of Nicorandil on Exercise Performance in Patients with Effort Angina: A Multicenter Trial Using a Treadmill Exercise Test , 1987, Journal of cardiovascular pharmacology.

[15]  K. Sakai,et al.  Cardiovascular Effects of a New Coronary Vasodilator N‐(2‐Hydroxyethyl)nicotinamide Nitrate (SG‐75): Comparison with Nitroglycerin and Diltiazem , 1981, Journal of cardiovascular pharmacology.